Systematix initiates Timex Group India coverage with Buy rating
Brokerage firm Systematix has initiated coverage on Timex Group India with a Buy rating and a target price of Rs 820, representing approximately 30% upside potential. The firm projects strong growth through FY29 driven by premiumisation, margin expansion, and robust cash generation.
Systematix has initiated equity research coverage on Timex Group India with a Buy rating, according to the announcement. The brokerage has set a target price of Rs 820 per share, implying around 30% upside from current levels. The initiation indicates Systematix's positive outlook on the watchmaker and timepiece company's growth trajectory over the coming fiscal years.
The brokerage projects strong financial performance through FY29, with revenue expected to grow at a compound annual growth rate (CAGR) of 29.1%. Earnings before interest, tax, depreciation and amortisation (EBITDA) is projected to expand at a CAGR of 37.3%, while adjusted profit after tax (PAT) is anticipated to grow at 40.5% CAGR. These projections reflect expectations of premiumisation in the product portfolio, margin expansion opportunities, and strong cash generation capabilities driving the company's performance.
The initiation of coverage by a major brokerage typically signals analyst confidence in a company's prospects and can influence institutional investor interest. For Timex Group India shareholders and potential investors, the Buy rating and growth projections suggest confidence in the company's ability to capitalise on consumer premiumisation trends and operational leverage. The projected margin expansion indicates potential for improved profitability even as revenues grow, suggesting efficient operational scaling. Strong cash generation forecasts may appeal to value-conscious investors seeking companies that convert earnings into actual cash flow.
Source: Markets-Economic Times
This article is an editorial summary sourced from third-party news providers and is produced by marketkin.com for informational purposes only. It does not constitute investment advice. Disclaimer